about
sameAs
P361
CalreticulinKeratin 1Interleukin 2CD34 antigenProteoglycan 2, bone marrowCD209e antigenFc receptor, IgE, low affinity II, alpha polypeptideCalnexinSelectin, plateletSelectin, lymphocyteGlucosidase, alpha, acidFucosidase, alpha-L- 1, tissueMannose-binding lectin (protein C) 2CD22 antigenKiller cell lectin-like receptor, subfamily D, member 1CD207 antigenZona pellucida glycoprotein 3BasiginSurfactant associated protein DPolycystin 1, transient receptor poteintial channel interactingAmylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase1,4-alpha-glucan branching enzyme 1Proteoglycan 2, pro eosinophil major basic proteinPolycystin 1, transient receptor potential channel interactingChitinase acidicC-type lectin domain containing 6AC-type lectin domain family 4 member GC-type lectin domain containing 9AC-type lectin like 1C-type lectin domain family 4 member FC-type lectin domain family 4 member MC-type lectin domain containing 5ADoublecortin domain containing 1F-box protein 6Ficolin 1Ficolin 3Contactin 2Complement component 4B (Chido blood group), copy 2Lectin, mannose binding 1Sialic acid binding Ig like lectin 6
P680
Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathwaysDual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domainParallel quantification of lectin-glycan interaction using ultrafiltrationStructural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domainSubstitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4AIsolation and characterization of a cDNA for human mouse, and rat full-length stem cell growth factor, a new member of C-type lectin superfamilyCrystal structure of human dendritic cell inhibitory receptor C-type lectin domain reveals the binding mode with N-glycanA novel gene (HIP) activated in human primary liver cancerAn activated L-selectin mutant with conserved equilibrium binding properties but enhanced ligand recognition under shear flowMechanism of pathogen recognition by human dectin-2.
P921
Q14633944-DE852A20-31A8-49B4-80B5-7280A9653463Q14864150-CB480D26-2515-4DA2-A3BE-516177D438DFQ14864519-2498D944-9191-48DB-A1C2-8BC9C720B4DAQ14873788-C0A37766-50C9-4843-985D-E1F79441853BQ14876058-9A44848C-2BEA-451C-A749-0BAD109DE2CCQ14876125-C4310800-1EB8-45E6-A92A-B6FF59F01B2AQ14876571-5853B43D-CFA7-4B75-88B4-4D7C16388DF9Q14876769-DB234964-6F19-4E9F-BF26-9EA3D6C3E297Q14881076-972E22B0-43F6-4B27-BAF4-AF651864F7F1Q14901674-3D356F96-6106-41ED-B66B-9E2F7698C3C6Q14902478-0701CD18-F057-432D-82FD-D86F2A8AA217Q14905583-00530387-1528-46E2-B0F7-942CDC372ED4Q14907668-953D0E67-9F35-4FC4-BBAF-43A76C77C10DQ14908196-04056321-F7D2-4EAF-93FC-45DEFDF1A1B4Q14908199-9E2E02F8-10D0-488E-8501-596F28836A93Q14911767-D33642EB-7F7F-440E-B8AB-5D10A190A7FBQ14911879-8ACF1266-22D3-4A02-8CD5-ACEEAE6D9448Q14911961-76A64AF6-520A-4C26-B8E6-1B8E5925CCD1Q14914147-37ED923E-1034-4E60-8199-5C1D24AF88E2Q14914569-32D3CDC1-01E0-4905-B1CF-435881FB272EQ1532471-CAFB4C6E-0F97-4FDB-B1F4-AE187CB3413AQ161537-4E64527F-65FF-4A10-B96C-B851D13B6255Q1886099-2B819EAB-A0FD-4E9E-85FC-A1C1E20A854BQ2044253-F2BEC8C8-1187-42A7-BEA1-EB13E63E97EBQ21100758-8D62385B-DB3E-459E-8163-F7A020079D4CQ21100826-2B1EDEB3-8011-4923-99FE-6D46414BB60BQ21100826-820E4D69-5E24-4E49-817E-BE05A3E355ABQ21100827-C65272E1-9B15-42B9-B4EF-040B9911EF49Q21100828-0DB2F09E-2BF1-4D9B-B2E4-51496A29D314Q21100829-008D9208-3779-4BA5-B573-13DF0EC11EC3Q21100830-4DD6425A-DDAC-4274-AB1E-B0235CE251BAQ21100841-61BA69D0-6EDB-4639-800E-7D00486D9EB2Q21100842-53D1FF3D-A928-4432-BEA8-9E29D4516F38Q21101015-9E9BAA1D-B412-4B42-B3B0-EB857CF8AFEBQ21101374-E4ECDFA6-A777-40FA-A537-5A4BAC51021DQ21101391-87CBE035-B3EB-4DE9-B7C5-FD846B89EE95Q21101395-EC65B25A-A568-4B9A-8F8B-E2A7E7BE8069Q21102442-A44429D4-8A86-43D4-81BF-8EC94BEC5046Q21102479-CE36110B-7CD4-49F9-B2CA-DE97D0ECF62AQ21103045-880F1B87-3863-4745-9515-CF59BAAF7643
P680
Q22254056-FBA7BA45-7DBB-4C23-824C-F38B21FF1E2BQ24293019-AF3EC9A6-96FE-4ACE-9493-BFECCE13B8CAQ24293519-5DAB1632-16CC-43D7-ADA6-9C11D7010A8FQ24311415-10B558D4-9A2D-4F33-BF0A-A636EC249ED3Q24318713-8188DF3F-6471-44C2-AC9E-61D0ADB05B24Q24324154-9D6AD5BF-8090-47F6-A2D5-F0BE9DB9B3E4Q27704307-BD2039A6-37FD-4AD3-9454-2F276C834629Q28116253-D4792352-E670-4AD7-AC97-2E0F28C8BD1BQ28117130-C6C8BF7D-75DC-4AF4-800F-6B8AA3B337C4Q38287866-EBE3755F-2F8F-4BC6-BAAC-D924A0064C0B
P921
description
Interacting selectively and no ...... (alditols), by oxidation of o
@en
moleculaire functie
@nl
name
Carbohydrate binding
@en-gb
binding av karbohydrat
@nn
carbohydrate binding
@en
liaison de carbohydrate
@fr
связывание углеводов
@ru
type
label
Carbohydrate binding
@en-gb
binding av karbohydrat
@nn
carbohydrate binding
@en
liaison de carbohydrate
@fr
связывание углеводов
@ru
altLabel
GO:0030246
@en
sugar binding
@en
prefLabel
Carbohydrate binding
@en-gb
binding av karbohydrat
@nn
carbohydrate binding
@en
liaison de carbohydrate
@fr
связывание углеводов
@ru
P279
P2888
P527
P686
GO:0030246